- Markets
Life sciences
- The trends
Life sciences are shifting from endpoint assays to continuous, image-based analysis, enabling kinetic and phenotypic insights. Automation and labor shortages are driving the adoption of vision-guided robotics and standardized workflows. Cell and gene therapy manufacturing relies on machine vision for in-process monitoring and GMP compliance.
Spatial biology expands tissue-level imaging and AI-based analysis. IVF automation uses vision for embryo assessment and micromanipulation. Regulatory pressure favors objective, traceable, image-based decision systems.
More information about cell interaction
Thanks to millisecond-scale autofocus, liquid lenses enable the rapid acquisition of multiple image slices, allowing high-quality 3D imaging. This provides rich spatial information on how cells interact with one another and with their surrounding environment.
Precise and sharp images with to non-moving parts
Replacing motorized stages with liquid lenses eliminates mechanical movement and the associated vibrations that can degrade image quality. This results in more stable imaging and improved consistency, especially in high-resolution, time-sensitive applications.
Compact system design
By eliminating the need for motorized stages, liquid lenses save valuable space, making them ideal for applications where laboratory space is limited or highly constrained.